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ABSTRACT
Oral squamous cell carcinoma (OSCC) is the sixth most frequently occurring
cancer worldwide. In the US approximately 50,000 new cases are diagnosed per
year, representing 90% of all the cancer cases of the oral cavity. When oral
squamous cell carcinoma is diagnosed it is often at an advanced stage. Novel
technology to enhance early detection of oral squamous cell carcinoma could
lead to early, less intensive treatments that increase patient survivorship as well
reduce toxicity.
In recent years Optical Coherence Tomography (OCT), a new non-ionizing, noninvasive method, has been utilized to visualize and diagnose malignant lesions in
diverse fields such as Ophthalmology, Gastroenterology, and Dermatology.
The objective of this current research was to demonstrate the efficacy of OCT for
diagnosing potentially malignant oral mucosal lesions of the tongue. Forty nine
mice were used in this study: 39 mice were treated with the carcinogen 4nitroquinoline 1-oxide (4NQO) for up to 13 weeks, and 10 mice served as
untreated controls. After specified treatment times, the posterior regions of the
tongues were evaluated with the use of OCT and histopathologic analyses.
Images of the histopathological sections were used as the gold standard, and
compared with the OCT images to verify the accuracy of the OCT diagnoses.
Two examiners evaluated clinical images and OCT images of the 49 specimens,
which

were

compared

with

the

histological

results.

This

comparison

demonstrated that clinicians were more accurate in the clinical identification of
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the normal aspect of the tongues, however some differences were found in the
results of the clinical evaluation of the treated group with the histological results.
The analyses of control group OCT images compared with the histological results
were moderately accurate as were those obtained with the clinical evaluation.
However, the comparison of results of the evaluation with the OCT of the treated
group and the histological analysis were different between the examiners and
were not correctly classified based on the histological results.
Comparison of these results demonstrated that clinical evaluation is important in
the identification of possible lesions in the oral cavity, however the criteria and
results may vary between dentists. OCT may become a useful imaging
technique, in which images resembling the microstructural changes occurring in
the epithelium of the oral cavity will guide the specialist to the precise area to be
evaluated with the histopathological analysis. This study demonstrated
differences between both examiners and variations in their consistency to
evaluate the OCT images. Despite that OCT is a high resolution imaging
technique in which images are similar to a low power microscope (4x), it is
important that the clinician is familiar with the normal appearance and changes
expected to be present in possible lesions that will be visualized in the OCT
images and histological sections, to avoid false positive or false negatives.

vii

ORAL CANCER
One of the major public health problems in the United States and many other
countries of the world is cancer; approximately one in four deaths in the United
States is related to cancer 1. Oral cancer is the eighth most-common cancer
among white males and the sixth most common cancer among Afro-American
males in the United States. In other regions of the world, especially in SouthCentral Asia, head and neck cancers are the most common malignancies found
in men. In the U.S., approximately 9,000 deaths per year are a consequence of
oral cancer, making it more deadly than breast cancer, cervical cancer and
prostate cancer. It has been estimated that one person is killed, every hour,
every day by oral cancer 2, 3.
Oral cancer is defined as any cancerous tissue growth located in the mouth. It
may arise as a primary lesion originating in any of the oral tissues or by
metastasis from a distant site of origin. Squamous cell carcinoma, which
develops from the stratified squamous epithelium that lines the mouth and
pharynx, is the most common cancer diagnosed of all the different types of
cancer that may be found in the oral cavity 4-6.
Squamous Cell Carcinoma (SCC) of the oral region is the sixth most common
malignancy worldwide 4. Approximately 50,000 new cases of squamous cell
carcinoma of the head and neck are diagnosed each year in the United States.
According to the American Cancer Society, in 2013 the total estimated number
of new cases of cancer in all anatomic sites was 1,660,290, and 41,380 was the
estimated number of new cases of oral and pharynx cancer, representing 2.5%
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of all the new cases of all sites in the body 7. Cancers of the lips, tongue, floor of
the mouth, palate, gingiva, alveolar mucosa, buccal mucosa, and oropharynx will
account for approximately 30,000 of these cases 5. According to Jemal et al. 48
% of all cancers located in the head and neck are located in the oral cavity and
90% of these are OSCC 8. In the past, squamous cell carcinoma of the oral cavity
was primarily found in male patients aged 60 years and older with an extensive
history of tobacco smoking, alcohol consumption and poor oral hygiene, which
may act additively or synergistically on a genetically susceptible individual.
However, some studies have shown increased incidence of oral SCC (OSCC)
among young patients, under 40 years of age, being more frequent in women
with no history of tobacco smoking. Other agents that may contribute to the rise
in the number of cases of oral cancer are various forms of drug abuse,
environmental factors, diet and the human papilloma virus (HPV), although the
HPV is not considered to be a significant risk factor of the anterior two thirds of
the tongue or the remaining oral cavity 3, 9-12.
Approximately 50-55 percent of patients with oral cancer survive beyond five
years; this rate has not improved during the last 50 years. When the oral cancer
is localized at diagnosis the five year survival rate is approximately 75%, but in
general this disease is diagnosed in stages 3 and 4 with lymph node metastasis,
reducing the probability of five-year survival to 26.5% 3, 12, 13.
The tongue is the most common site for oral cancer in both American men and
women. This is also true of developed countries, however, in some developing
countries, site prevalences may differ owing to culture-specific habits, for
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example, nasopharyngeal cancer in Southeast Asia and buccal cancer in India
are the most common oral and pharyngeal sites 5. Patients with oral tongue
squamous cell carcinoma have a significantly worse prognosis than those with
similar lesions of the oropharynx, larynx, hypopharynx and other sites of the oral
cavity 4. The tongue includes a rich lymphatic network and a complex structure of
muscles that make it the site most frequently associated with cervical metastasis
compared to cancer of other sites in the oral cavity 10.
Other common areas of oral cancer are: floor of the mouth, lip mucosa,
retromolar gingiva, hard palate, buccal mucosa, lower and upper alveolar ridge.
But cancers that develop in the tongue, floor of the mouth and lip mucosa
represent more than 70% of all oral cancers 11.

3

POTENTIALLY MALIGNANT LESIONS
At an early stage tongue OSCC is typically asymptomatic, making early
diagnosis challenging

14

. Therefore, clinical evaluation and possibly soft tissue

imaging are the key methods for early identification and diagnosis of oral tongue
squamous cell carcinoma. It is vitally important to recognize clinical signs and
symptoms suggestive of oral squamous cell carcinoma at an early stage. These
include oral ulceration (non-healing), raised, everted, exophytic and indurated
lesions, abnormal swellings, loss of tongue mobility, dysarthria, otalgia,
cauliflower-like or warty growths, abnormal localized tooth mobility, non-healing
tooth sockets, color changes in mucosa (red, white or speckled patches),
erosive, raw mucosal patches, reduced or altered orofacial sensation

15

. One of

the greatest challenges that the dentist has is the dilemma to predict which of
these lesions will progress to neoplasia, like the most frequent in the oral cavity,
oral squamous cell carcinoma. Nevertheless, the biological relevance of benign
and malignant lesions may not be distinguishable on the basis of their clinical
appearance

12, 16

.

Dentists must be alert to the presence of subtle lesions that could be considered
as premalignant and early stage malignant lesions. The World Health
Organization defines premalignant lesions as morphologically altered tissue in
which cancer is more likely to occur than in its apparently normal counterpart.
The most common lesions to be considered as potentially malignant lesions in
the oral cavity are oral leukoplakia and oral erythroplakia. Other lesions to be
considered as potentially malignant are reverse smoker’s palate, oral submucous
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fibrosis and tobacco pouch keratosis

16, 17

. Clinicians should focus their attention

on high risk sites where 90% of premalignant lesions arise; these are the floor of
the mouth, ventrolateral aspect of tongue and soft palate 18.
Leukoplakia is defined as a white patch or plaque that cannot be characterized
clinically or pathologically as any other disease; the most common sites are
buccal mucosa, alveolar mucosa and lower lip. Lesions that arise on the floor of
the mouth, lateral tongue and lower lip are most likely to show dysplastic or
malignant changes and are considered high risk sites

17

. Any leukoplakia that

persists more than 10-14 days after conservative treatment should be considered
as a potentially premalignant condition 19.
Erythroplakia is defined as lesions of the oral mucosa that present as red areas
and cannot be diagnosed as any other definable lesion. This lesion is uncommon
compared with leukoplakia, and is found predominantly in middle aged and
elderly people, with predilection for soft palate, buccal mucosa, tonsillar pillars
and floor of the mouth. Some differences in location were found depending on
gender. In men the most commonly affected site is the floor of the mouth,
followed by the retromolar trigone, while in women erythroplakia is more common
in the mandibular alveolar mucosa, mandibular gingiva and mandibular vestibule.
Oral erythroplakia has the highest risk for malignant transformation compared
with other premalignant lesions 17, 19.
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DIAGNOSTIC METHODS
Dentists utilize a variety of aids to diagnose oral precancerous and cancerous
lesions. As with any test, proper case selection and correct performance of the
test itself are critical to the sensitivity and specificity of its result. Some of these
aids are: brush cytology (brush biopsy), tissue fluorescence, and toluidine blue
staining. Some techniques utilized by specialists are: punch biopsy, scalpel
biopsy, fine-needle aspiration cytology and sentinel node biopsy 19.
Imaging techniques used to detect squamous cell carcinoma include plain
radiography, computed tomography, magnetic resonance imaging and molecular
imaging

18, 20, 21

. These imaging techniques are used to define the borders of the

affected tissues (bone or soft tissue), the presence of internal contents in the
lesion, regional lymphatic spread and the effects on adjacent tissues (expansion,
remodeling, displacement, destruction). OSCC is difficult to diagnose in an early
stage because the malignant changes are confined to the soft tissues. Most oral
lesions are benign, but many have an appearance that may be confused with a
malignant lesion, and some previously considered benign are now classified as
premalignant because they have been statistically correlated with subsequent
cancerous changes. Conversely, some malignant lesions seen in an early stage
may be mistaken for a benign change. Any oral lesion that does not regress
spontaneously or respond to the usual therapeutic measures should be
considered potentially malignant until histologically shown to be benign 20, 22.
Recently, Optical Coherence Tomography (OCT) has been implemented in
dermatology and oncology to determine the presence of soft tissue lesions

6

23

.

OCT is a noninvasive diagnostic imaging modality with a high resolution that can
give near histologic images with a safe broadband light source. This imaging
technique measures backscattered light generated from an infrared light source
directed at the tissues being examined

24

. Broadband laser light waves are

emitted from a source and directed toward a beam splitter. One wave is sent
toward a reference mirror with a known path length and the other toward the
tissue sample. After the 2 beams reflect off the reference mirror and the tissue
surfaces at varying depths in the sample, the reflected light is directed back
toward the beam splitter, where the waves are recombined and read with a photo
detector

25

(Fig. 1). OCT is the optical equivalent of ultrasound, using light

instead of sound waves; it is a noninvasive and nondestructive method for
imaging the microstructural detail of oral tissue in situ. Resolution up to 1-2 µm
can be achieved, being 100-250 times greater than high-resolution ultrasound

26

.

It is capable of evaluating the health of hard and soft tissue by providing a crosssectional “optical biopsy” of tissue up to 3 mm in depth from the surface. The
resultant images have an axial resolution of 1–10 µm, capturing structural details
without the use of ionizing radiation and not possible with conventional x-ray
imaging technologies

27

. OCT is considered to be an optical “biopsy” by some

authors because the image resembles the architecture observed in histology

26,

27

. For this technique to become clinically interpretable and relevant, the

structures visualized must be correlated with the corresponding tissue
microstructures 28.
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Fig. 1 Diagram of the Optical Coherence Tomography based on:
http://www.answers.com/topic/optical-coherence-tomography and
In Vivo Optical Coherence Tomography for the Diagnosis of Oral Malignancy, WilderSmith et al, Lasers in Surgery and Medicine 35:269–275 (2004)

The resolution of OCT permits in vivo noninvasive imaging of the macroscopic
characteristics of epithelial and sub-epithelial structures including: depth and
thickness, peripheral margins, and

potential histopathological appearance

29

.

OCT has been used to detect soft tissue malignant lesions in the oral cavity in a
small number of studies but less frequently than with other areas such as
ophthalmology, gastroenterology, urology and gynecology

30-33

.

Current

identification and diagnosis of potentially malignant and malignant oral mucosal
lesions rely upon histologic and cytologic examination performed by a pathologist
after suspicious tissue is biopsied. These methods represent the gold standard
for cancer diagnosis.

However, they have some limitations, including the

invasive nature of the biopsy, cost of the procedure, and typically two-three days
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from time of biopsy to obtaining the histopathologic results.

Importantly,

diagnostic interpretation of the tissue sample may vary among pathologists 29, 34.
Additionally OSCC may not be detected until clinically advanced; subtle oral
mucosal lesions may be overlooked by the clinician during visual inspection of
the tissue

35

. Early malignant changes are still overlooked using conventional

oral examination; an example of this is dysplasia that may be found in “clinically
normal mucosa”

36

. A recent meta-analysis reported 93% sensitivity for

conventional oral examination, while specificity was only 31%
devices such as VELscope

36, 37

, Identafi

36

. Recently some

36, 38

, and Narrow Band Imaging (NBI)

36, 39

, have been used to improve the evaluation of the oral mucosa to identify

potential malignant lesions. Nevertheless, the differentiation of low and high risk
lesions using some of these devices remains undetermined, with false positives
obtained in some cases. These devices may affect the lesion’s appearance in
terms of brightness, texture and delineation of the margins but they have not
been shown to enhance the ability to identify potentially malignant lesions,
especially those that are not visible under normal operatory lighting. Early-stage
lesions often are asymptomatic and may mimic other conditions, whereas others
may not be readily evident in routine examination. Also, because malignant and
benign lesions may not be clinically distinguishable, the clinician cannot predict
the biological relevance of lesions on the basis of their physical features alone 12.
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OBJECTIVES
The objective of this study is to demonstrate the efficacy of Optical Coherence
Tomography to diagnose potentially malignant oral mucosal lesions of the
tongue.

HYPOTHESIS
OCT image findings in potentially malignant oral mucosal lesions of the tongue
are comparable to histopathologic findings.

SPECIFIC AIMS
1) To induce potential oral tongue SCC in mice using the carcinogen 4nitroquinoline 1-oxide;
2) Obtain OCT images of the tongue lesions and compare them with
histopathological sections of the lesions; and
3) Determine quantitatively the correlation between OCT and histopathological
images for specific structural parameters.

10

MATERIALS AND METHODS
Study Design:
All experimental procedures were performed at the University of Connecticut
Health Center in complete concordance with the guidelines of an approved
protocol (ACC# 100776-1016) for animal experimentation and in compliance with
the guidelines set forth in the Guide for Care and Use of Laboratory Animals.
Forty nine female C57BL/6J mice, 7 weeks-old, were used for this study, 10 as a
control group and 39 with induced oral tongue squamous cell carcinoma. A total
of fifty mice were received to start this project, but the first day of the experiment
one mouse died, finishing with a total of 49 mice. The animals were acquired
from Jackson Laboratory, Bar Harbor, Maine, United States of America. The
OCT instrument that was used for this study was donated by Axsun
Technologies, Inc. (Axsun Technologies, Inc., Billerica, MA) to the Section of
Oral and Maxillofacial Radiology of the School of Dental Medicine, University of
Connecticut. This device is used for research specifically in the area of dentistry.

Inducing Potentially Malignant Lesions in the Oral Cavity
After 6 days of acclimation to their surroundings and a 12-hour light/dark cycle,
mice were randomly placed in 1 of 10 groups, each group with a total of 5 mice
except one group that had 4 mice. The first two groups with ten mice in total
comprised the control group and the remaining 39 mice were treated with the
carcinogen agent (See experimental timeline, Fig. 2.). The mice were maintained
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on standard rodent chow and water ad libitum, under normal laboratory
conditions in the Center for Comparative Medicine, UCHC, in Room LB033C.
The first day of the experiment, a solution consisting of distilled water with 100
p.p.m. 4-nitroquinoline 1-oxide (4NQO) was provided to the test group to
chemically induce potentially malignant mucosal lesions of the tongue. The
4NQO is water-soluble and can be administered orally in drinking water. (The
4NQO was acquired through Sigma- Aldrich, St. Louis, MO.) A fresh batch of
water was prepared every week for each of the first to thirteenth week of
carcinogen treatment. The mice drank this water with dilute 4NQO for up to
thirteen successive weeks. Control mice received water without any additive. The
level in the water bottles was monitored two times per week.

Figure 2: Experimental Timeline

Tanaka states that this carcinogenic agent produces all the stages of oral
carcinogenesis with similar histological appearance and molecular changes that
are observed in the human system

40

. The 4NQO is a synthetic carcinogen

derivative of a quinoline, is soluble in water and sensitive to high temperature
12

and light (the 4NQO solution was stored in a brown glass bottle and brown glass
water bottles were used with the mouse cages). One of the advantages of this
carcinogen agent is that it is capable of inducing sequentially the different phases
of carcinogenesis (hyperplasia, dysplasia, severe dysplasia, carcinoma in situ
and OSSC)

41

. The lesions obtained with the use of the 4NQO appear similar to

damage imposed by other carcinogens present in tobacco, which is a major risk
factor for oral cancer 42.
The 4NQO is a powerful carcinogen that may act in several organs, and it can
specifically induce tongue SCC when it is applied in low concentrations via
drinking water 43. This potent mutagen and carcinogen, after metabolic activation,
binds to DNA producing three main adducts: two on guanine (dGuo-N2-AQO,
dGuo-C8-AQO) and one on adenine (dAdo-N6-AQO)

44

. The 4NQO induces

histological as well as molecular changes similar to those observed in human
oral carcinogenesis. 4NQO has been used for the induction of oral cancer
including dorsal and ventral tongue, palate and aerodigestive tract.

Wellness Monitoring and Euthanasia
Depending on the group to which the mice were randomly assigned, they were
exposed to 4NQO added to the drinking water or no treatment at all. In order to
monitor the food and water intake, and the appearance and activity of the mice
during the experiment, the mice were observed twice per week and weighed
once per week, and these data were recorded in an Excel spreadsheet. In
general, the mice gained or maintained their weight; a few treated mice lost a
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small amount of weight, not more than 10% of body weight (between 0.5-1 g),
over the full course of the experiment. Although both groups gained weight
during the course of the experiment, the mice in the treated group did not gain as
much as the ones in the control group. When the mice arrived at the Center for
Comparative Medicine at UCHC, the mean weight was 18.70 g. Their weight
increased progressively until the 14th week, when the experiment finished; the
mean weight of the two last mice of the control group was 23.95 g compared to
the mean of the last 10 mice of the treated group of 20.40 g (Fig. 3).

Mean Control

Mean Treated

31.25
25

Weight

18.75
12.5
6.25
0
1

2

3

4

5

6

7

Week

8

9

10

11

12

13

14

Fig. 3 Comparison of the body weight for the
mice in control group vs Treated group

The first day of the experiment two mice of the control group were
euthanized by CO2 inhalation. Subsequently, starting on the fourth week
and every three weeks thereafter, 2 mice of the control group and 10 of
the treated group were sacrificed using the same method of CO2
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inhalation followed by cardiac transsection. The last 2 control mice and the
last 10 treated mice were euthanized on the fourteenth week.
Obtaining OCT Images and Histological Sections:
After euthanasia, the tongues of the mice were excised and placed in a container
with cold Phosphate Buffered Saline (PBS) identified with the number of the
respective specimen. In general the location of the excision was at the posterior
aspect of the throat.
After excision of the tongues a clinical evaluation was performed to evaluate any
macroscopic changes, the tongues were photographed using a Canon camera
EOS 60D with a Canon 28-135 IS lens, and the images were saved as RAW
images.
The posterior region of each tongue was scanned, using the OCT (Axsun
Technologies, Inc), as many times as necessary to completely scan the area of
its dorsum and ventral aspect. The images obtained from the scan were saved
as TIFF images. To standardize the scan procedure, the tongues were placed in
the middle portion of a round plastic device, the scanner was positioned in a
perpendicular position to the table where the specimen was located; the same
procedure was used to scan all 49 tongues. Once the tongues were scanned
using the OCT they were fixed in 10% buffered formalin.
The fixed tongues were sent to the Section of Oral and Maxillofacial Pathology to
proceed with

a histological study of each specimen. The tongues were

embedded in paraffin and the histological sections were stained with hematoxylin
and eosin and coverslipped. The sections were scanned into the Aperio virtual
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microscope system in the Faculty Instructional Technology Service, UCHC, using
either the 20X or 40X objective lens. The sections were histologically evaluated
in the same orientation as the OCT was previously performed.
Image Analysis:
Images obtained by OCT were coded and analyzed by a radiologist at the
Section

of Oral and Maxillofacial Radiology at the University of Connecticut

School of Dental Medicine. The Section of Oral and Maxillofacial Pathology
provided histopathologic evaluations of the tongue sections. The criteria used for
the evaluations were based on the histological changes visualized in the different
sections, such as: hyperkeratinization, changes of the filiform papillae, increased
thickness of the stratified squamous epithelium and changes of the basement
membrane. According to these, the sections were categorized as: Normal,
Hyperkeratosis, Hyperkeratosis with maturational disturbance and Maturational
disturbance. A radiologist and pathologist evaluated the clinical images of the
different tongues. The criteria to evaluate the tongues were based on the clinical
appearance, color of the dorsum and ventral aspect of the tongues and the
presence of any potential lesion such as leukoplakia or erythroplakia. According
to these, the tongues were classified as: Normal, that included all tongues with
pink appearance, smooth surface and no lesions on

their dorsal, ventral or

lateral aspects, possible lesion was used when the evaluators considered that
the tongues did not have a normal appearance but were not sure of the presence
of an entity affecting the tongues, and the final category was lesion, that included

16

changes of the appearance of the tongue and presence of probable
hyperkeratosis or other lesions such as leukoplakia or erythroplakia.
The OCT images of the posterior tongue were evaluated using the following
criteria: changes in the keratinized layer, changes in the thickness of the
keratinized layer, in the thickness of the stratified squamous epithelial layer and
changes observed in the basement membrane. The areas to be evaluated were
the posterior, middle and tip of each tongue. According to the changes that were
visualized the tongues were classified as Normal, when no changes were noted,
possible lesion, when some changes were noted but the evaluators were not
sure of the presence of a lesion, and the final option was lesion, that included
significant changes noted by the evaluators (Fig. 4). The evaluation of the OCT
images was repeated by the same evaluators one week after the first evaluation
was done.

a

b

c

Fig. 4 Histological (panels a and b) and OCT images (panel c) of the middle portion
of normal mouse tongue. Scale bars = 600 µm in (a) and 200 µm in (b).
17

The clinical images and the OCT images were presented in a Keynote slide show
(Apple, Cupertino, CA). The first four slides showed the normal aspect of the
tongues, clinically and OCT images as well; after these four slides, the different
clinical images and OCT sections were presented in a random order. For the
second evaluation of the OCT images the order was changed to avoid bias with
the previous results. The results obtained in both the clinical and OCT
evaluations were compared with the histological classification determined by an
oral pathologist, which was used as the gold standard.

18

RESULTS
All the mice except one were included in the study. The one animal excluded
from analysis died on the first day of the experiment. All mice included in the
study remained in apparent healthy condition and had a slight increase in body
weight (Fig. 3).
Clinical evaluation
Forty nine mice were used in this experiment, 10 of these were randomly
selected for the control group and the remaining 39 mice were included in
the treated group. The majority of the clinical changes noted in the treated
group occurred on the dorsum of the tongue with the exception of one
specimen that presented a verrucous appearing lesion on its ventral
aspect (Fig. 5).

a

b

c

d

Fig 5. Comparison of clinical images: a) Normal appearance of mice with no
treatment sacrificed in week 14 . Fig. b,c and d. Tongues of mice receiving 4NQO
dissolved in drinking water and sacrificed at weeks 8, 11 and 14, respectively. Note
the verrucous lesion in ventral aspect of the tongue (d).
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During the clinical evaluation of the untreated tongues, evaluator 1
classified 8 of these as normal and 2 with a possible lesion, while
evaluator 2 considered that 6 of 10 were normal, 3 with a possible lesion
and 1 was classified with a lesion (Fig. 6).

8Normal

8

Possible Lesion

Lesion

6

6

4

2

3

2

1

0

0
Evaluator 1

Evaluator 2

Fig. 6 Clinical evaluation of Control group

,These results were compared with the histological results in order to determine
the accuracy of the clinical evaluation. This accuracy in the evaluation of the
normal group was 80% for evaluator 1 and 60% for evaluator 2, but 20% - 40%
of the specimens were categorized as possible lesion or lesion by the two
evaluators. For this evaluation they did not have the opportunity to evaluate the
tongues grossly, but only by observing images.
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The most substantial difference in the clinical evaluation was found in the treated
group. Evaluator 1 classified 18 as normal tongues while 21 were classified with
possible lesions. The results of evaluator 2 contrasted with those of the first
evaluator in that only 2 tongues were classified as normal while 12 were
classified as possible lesion and 25 of the 39 specimens were categorized as
having lesions (Fig. 7).

Normal

Possible Lesion

Lesion

30

25
21

22.5

18
15

12
7.5

2

0

0
Evaluator 1

Evaluator 2

Fig. 7 Clinical evaluation of Treated group

The accuracy of this evaluation differed from the one obtained in the control
group, because more specimens were classified as having possible lesions and
lesions. For this reason, two comparisons were made, the first evaluation
between the normal vs. lesions and the second corresponding to the evaluation
of normal vs. possible lesions. Both evaluations were compared to the obtained
histological sections.
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Histologic results demonstrated that 9 specimens of the treated group had no
histological changes and were classified as normal, while 30

specimens

presented some variations such as Hyperkeratosis, Hyperplasia with normal
maturation, Hyperkeratosis with maturational disturbance and Maturational
disturbance; all of these categories were grouped as lesion.
Evaluator 1 was accurate in the identification of 3 treated tongues of 9 that were
histologically diagnosed as normal while evaluator 2 identified correctly only 1 of
the 9 tongues histologically classified as normal, but correctly identified 22 of 30
as tongues with lesions (Fig. 8).

Normal

30

Lesion

30

22

22.5

15

7.5

0

9
3
0

1

Evaluator 1
Evaluator 2
Histolog.
Results

Fig. 8 Clinical Evaluation- Histological results, Normal vs Lesion

The results of the evaluation of the specimens that were categorized by the
evaluators as possible lesions were compared to the tongues histologically
diagnosed with lesions. For evaluator 1, 15 tongues were selected as having a
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possible lesion of a total of 30 that were histologically diagnosed with some
changes that were considered as lesions, while evaluator 2 identified 7 tongues
as having possible lesions. Both evaluators used the category “possible lesion”
when they considered that the tongues were not normal but did not exhibit
enough changes to be considered as tongues with lesion (Fig. 9).
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Fig. 9 Clinical evaluation- Histological results, Normal vs Possible Lesion

For the accuracy of the clinical evaluation of the treated group, evaluator 1
correctly identified 30% of the tongues as normal while 50% of the tongues
histologically diagnosed with lesions were clinically identified as having possible
lesions. Evaluator 2 correctly identified 1 specimen as normal, representing 11%
of the diagnoses of the normal tongues. However, 29 tongues were identified as
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having possible lesions or lesions, representing 97% of the tongues with lesions
(Fig. 10).

OCT evaluation
The results obtained from the two evaluations made by the two examiners were
compared to the histological results obtained from the Department of Oral
Pathology of the University of Connecticut Health Center. No histologic changes
were noted in the control group as was expected, however only 30 specimens of
the treated group showed some histological changes such as hyperkeratosis,
Hyperkeratosis with maturational disturbance and only maturational disturbance.

Fig. 10 Clinical evaluation- Histological results, Possible Lesion + Lesion

The most common changes noted in the specimens were hyperkeratosis
followed by maturational disturbance (Figs. 11- 15).
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a

b

c

Fig. 11. Histological (Panels a and b) and OCT( Panel c) images of the posterior aspect
of a mouse tongue with hyperkeratosis (sacrificed on the 5th week of the experiment)
Scale bars = 600 µm in (a) and 200 µm in (b).
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a

b

c

Fig. 12 Histological (Panels a and b) and OCT( Panel c) images of the middle aspect of
a mouse tongue with hyperkeratosis (sacrificed on the 8th week of the experiment)
Scale bars = 600 µm in (a) and 200 µm in (b).
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a

b

Fig.13 Histological (Panels a and b) and OCT( Panel c) images of the middle aspect of a
mouse tongue with crowding in the stratum spinosum (sacrificed on the 11th week of the
experiment) Scale bars = 600 µm in (a) and 200 µm in (b).

c
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Fig. 14 Histological (Panels a and b) and OCT( Panel c) images of the middle aspect of
a mouse tongue with pleomorphism in the stratum spinosum (sacrificed on the 14 th
week of the experiment) Scale bars = 600 µm in (a) and 200 µm in (b).

a

b

c
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Fig. 15 Histological image of the middle portion of a normal mouse tongue
(sacrificed on the 14th week)
Scale bars = 600 µm in (a) and 200 µm in (b).
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The evaluation of the OCT images showed a marked difference between the two
evaluators. A week after the clinical evaluation was done, the evaluators
classified the OCT images; these images were presented in a 15” screen. All the
images were randomly inserted in a Keynote slideshow. The first four slides
showed the OCT images with the histological sections of the same site; the
remainder of the slideshow did not contain any histological sections. The order of
the image presentation in the slideshow was different to avoid bias in the
evaluations.
The results obtained from Evaluator 1 for the two OCT evaluations of the control
tongues were: in the first evaluation 10 of 10 were identified as normal and in the
second evaluation only 9 tongues were accurately identified as normal while 1
tongue was categorized as having a lesion. Evaluator two identified 7 tongues as
normal, 2 as tongues with possible lesions and 1 with a lesion, while in the
second evaluation 8 tongues were classified as normal and 2 as having possible
lesions. The accuracy for the evaluation of the OCT images compared to the
histological results was very high for both evaluators. For evaluator 1 the
accuracy rate was 90-100% while for evaluator 2 the accuracy rate was 70-80%
(Fig. 16).
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Fig. 16 Evaluation of OCT images and histological results of control group

For the first evaluation of the tongues of the treated group, Evaluator 1 classified
36 of the 39 tongues that were treated with 4NQO as normal, with no changes,
while 3 were classified as having possible lesions. On the other hand, Evaluator
2 considered that only 8 of the tongues of the treated group were normal and had
no changes in the epithelium, while 18 were classified as having possible lesions
and 13 had lesions.
A week later the OCT evaluation was repeated, changing the order of the slides,
and evaluating the same parameters. Evaluator 1 considered that 36 tongues
had no changes and only 3 could have possible lesions. However, Evaluator 2
classified 10 tongues as normal, 12 as having possible lesions and 17 were
included in the group of tongues with lesions. According to the histological
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evaluation 9 of 39 treated tongues had no histological changes and the rest had
some changes and were classified as lesions (Fig. 17).

Normal

40

36

Possible Lesion

Lesion

36

30

30
20

18
13

10

3
0

8
0

17
10 12

1 2

1 OCT Eval
2 OCT Eval
1
1

9
0

1 OCT Eval
2

2 OCT Eval
2

Histol.
Results

Fig 17. Evaluation of OCT images- Histological results, Treated group

The accuracy of the results obtained in the evaluation of the treated group differs
from the evaluation of the control group. Evaluator 1 was accurate in the
identification of the tongues that had no changes. In the first evaluation 8 tongues
were correctly identified and for the second evaluation 7 were selected as
normal, however, no tongues were classified as tongues with lesions in both
evaluations. Evaluator 2 identified 2 of the 9 tongues histologically diagnosed
with no changes and in the second evaluation only 4 were identified as normal.
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However, 10 tongues were correctly identified as having lesions in the first
evaluation while 15 of the 30 tongues with lesions were identified in the second
evaluation (Fig. 18).
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Fig. 18 Accuracy of evaluation of OCT-histological results, treated group

Many of the tongues that were evaluated in the treated group were classified as
having possible lesions by both evaluators. The tongues that were included in the
following results were those that were identified as having possible lesions with
the OCT and histologically diagnosed with lesions. For Evaluator 1, in the first
evaluation, 2 tongues were classified as possible lesion while in the second
evaluation 1 tongue was identified as having a possible lesion, Evaluator 2
selected 14 specimens in the first evaluation as possible lesion while 9 were
selected in the second evaluation (Fig. 19).
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Fig. 19 Evaluation of OCT-Histological results treated group
Possible lesion-Lesion

For accuracy of the treated group with histologically diagnosed lesions, evaluator
1 correctly identified 3.33%- 6.66% of the tongues as having possible lesions
while evaluator 2 correctly identified 30% and 46.66% of the tongues with lesions
and 33.33% and 50% of the

specimens were identified as having possible

lesions (Fig. 20).
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Fig.20 Evaluation OCT - Histological results, Possible Lesion+ Lesion

Comparing the results obtained in the clinical and OCT evaluations, it is evident
that the results of evaluator 1 were very consistent: in the normal group, 8
tongues were identified as normal in the first evaluation with the OCT and
classified in the same group in the clinical evaluation, while in the second
evaluation 7 of the tongues were consistent with the clinical evaluation of the
control group. For evaluator 2, however, in the clinical evaluation 6 tongues were
included as normal, 3 as having a possible lesion and only one was defined as
having a lesion. For this evaluator, only 3 tongues coincided with the clinical
evaluation in the first evaluation with OCT,
evaluation (Fig. 21)
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and 4 tongues in the second

Normal
8

8

8

Possible Lesion

Lesion

7

6

6

4
2
0

2

3
0

0 0

4

3
1

0 0

Clinic. Eval
1 OCT Eval.
1
2 OCT Eval
1
Clinic. Eval
1
2

0

0

1 OCT Eval
2

0

0

2 OCT Eval
2

Fig. 21 Comparison of Clinical and OCT Evaluation, Control group

Comparison of the clinical evaluation and OCT images in the treated group
differed from the results obtained in the control group. For evaluator 1, 18
tongues were classified as normal in the clinical evaluation while 21 were
considered as having a possible lesion. In the first evaluation with OCT, 17
tongues were consistent with the normal diagnosis, and in the second evaluation
with OCT, 18 tongues were considered as normal while three tongues were
included as having a possible lesion or lesion. In contrast, evaluator 2 considered
that only 2 tongues had a normal clinical appearance, 12 had a possible lesion
and the remaining 25 had a lesion. In the first evaluation with OCT there was no
constancy in the identification of normal tongues in the treated group, while a
total of 16 tongues where included as having a possible lesion or lesion. In the
second evaluation with OCT, only 1 specimen coincided with the clinical
diagnosis as a normal tongue while 4 and 12 tongues were classified as having a
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possible lesion or lesion, respectively (Fig. 22). The results of the evaluations are
summarized in Table 1.

Normal

30
22.5

18

Possible Lesion

21

Lesion

25
17

18

15

12

7.5
0

0

2

0

1 2

7

2

Clinic. Eval
1 OCT Eval.
1
2 OCT Eval
1
1

12

9

0
Clinic. Eval
2

1

1 OCT Eval.
2

4

2 OCT Eval
2

Fig, 22 Comparison of Clinical - OCT evaluation, treated group
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Table 1. Results of Clinical and OCT evaluations and histological analysis
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STATISTICAL ANALYSIS
Variables evaluated were: 1) presence or absence of the lesion, 2) changes in
the thickness of the stratified squamous epithelial layer, 3) changes in the
keratinized, stratified squamous epithelium. The presence of the lesion was rated
as: No lesion, possible lesion and lesion present. The images of the control
group were used as reference of the normal tissue. Images obtained with the
OCT resembled the architecture of the tissue evaluated in the histopathologic
exam, giving an indication of the structural changes as a consequence of the
potentially malignant oral mucosal lesion. With the OCT it is difficult to try to
identify precisely which cells are affected, compared to the histopathologic
sections that provide a positive identification of the affected cells.
Statistical analysis was performed utilizing the Kappa statistic, which is used
when it is necessary to evaluate the results of physical exam findings,
radiographic interpretations or other diagnostic tests, where the interpretation or
diagnosis depends on the subjective interpretation of the evaluators. A Kappa of
0 indicates the amount of agreement if the evaluators were simply guessing, and
a Kappa of 1 indicates a perfect agreement
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. Based on the standard of this

study K=0.6 was used as a good agreement.
According to the Kappa statistics, when the clinical evaluation of Evaluator 1 was
compared to the histological results, the result was K=0.0335 that means a slight
level of agreement, compared to the result obtained for Evaluator 2 where
K=0.4439 with a moderate level of agreement (Table 2).

39

Measure

Weighted Kappa

Level of
agreement

Evaluator 1 Clinic Eval. vs Histolog. results

0.0335 Slight

Evaluator 1 OCT 1 Eval. vs Histolog. results

0.0055 Slight

Evaluator 1 OCT 1 Eval vs Clinical Eval

0.0511 Slight

Evaluator 1 OCT 2 Eval. vs Histolog. results

-0.1125 None/negative

Evaluator 1 OCT 2 Eval vs Clinical Eval

0.0855 Slight

Evaluator 1 consistency

0.3691 Fair

Evaluator 2 Clinic Eval. vs Histolog. results

0.4439 Moderate

Evaluator 2 OCT 1 Eval. vs Histolog. results

0.1874 Slight

Evaluator 2 OCT 1 Eval vs Clinical Eval

0.0982 Slight

Evaluator 2 OCT 2 Eval. vs Histolog. results

0.3905 Fair

Evaluator 2 OCT 2 Eval vs Clinical Eval

0.0983 Slight

Evaluator 2 consistency

0.1062 Slight

Inter-examiner Clinical Eval. consistency

0.0681 Slight

Inter-examiner OCT 1 Eval. consistency

-0.0035 None/negative

Inter-examiner OCT 2 Eval. consistency

0.0179 Slight

Table 2. Results of the Kappa statistics

When the OCT evaluation was compared to the histological results, the results
obtained for Evaluator 1 were very different between the first evaluation with
OCT, where K=0.055, and for the second evaluation, where K=-0.1125. There
was a slight level of agreement for the first evaluation and none or negative
agreement for the second evaluation. However, the results obtained by Evaluator
2 demonstrated an increase of the level of agreement from slight to fair
agreement. The results obtained were K=0.1874 for the first evaluation with OCT
and K= 0.3905 for the second evaluation with OCT.
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Results of the comparison between the evaluation of the OCT and the clinical
evaluation were: for the first evaluation of Evaluator 1, K=0.0511 while the
second evaluation of the OCT had a statistical result of K=0.0855, maintaining a
slight level of agreement. The results obtained for the OCT evaluations and the
clinical evaluation for Evaluator 2 were very consistent, for the first evaluation
K=0.0982 while the second evaluation K=0.0983, with a slight level of agreement
in both evaluations.
The determinations of the first evaluator were very consistent with a K=0.3691,
while Evaluator 2 had a slight consistency with K=0.1062.
During this project, there was a slight consistency in the clinical evaluation
between both examiners with K=0.0681. The consistency between the examiners
for the OCT evaluations was quite different, while the K statistic for the first
evaluation was negative with a value of -0.0035, the second evaluation was
slightly consistent with K=0.0179.
Evaluator 1, in general, had a low rate of correct diagnoses, based on clinical
and OCT evaluations, however was fairly self-consistent in the evaluation of the
OCT images Evaluator 2 was moderately successful at correctly diagnosing
lesions during the clinical evaluation but was not consistent with the evaluation of
the OCT images. The level of agreement of both evaluators for their clinical
evaluations vs. OCT evaluations was very low; the same results were obtained in
the inter-examiner comparison
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DISCUSSION
In this study our aim was to demonstrate the efficacy of Optical Coherence
Tomography to diagnose potentially malignant oral mucosal lesions of the
tongue. The reason for investigating this topic is that the oral squamous cell
carcinoma is frequently diagnosed in an advanced stage, and the survival rate
may improve if it is diagnosed in an early stage.
Screening based on visual and tactile examinations is recommended, which may
result in early detection of oral cancer

12

. The main objective of screening is to

reduce mortality and morbidity from the disease by preventing progression of the
lesion
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. One of the recommendations reported in the literature is that dentists

must perform an exhaustive clinical evaluation to find possible changes in areas
such as the ventro-lateral aspect of the tongue, floor of the mouth and cheeks.
These are the most frequent sites for oral squamous cell carcinoma,
nevertheless more than 50% of oral cancers had spread to distant places of the
body before they were originally diagnosed. This may suggest that many
providers, or their patients or both, are either failing to recognize premalignant
changes of the oral mucosa or the patients are evading clinical evaluation of
these findings 47.
In a survey conducted in 1998 by the National Health Interview Survey (NHIS), it
was concluded that only 20.1% of American adults have ever received an oral
cancer examination while other groups that include Afro-Americans, Hispanics
and patients with low education were significantly less likely to have had such an
examination. Another factor to be considered is the knowledge about oral cancer.
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In a survey of American adults, 66% to 85% responded that they had heard
about oral cancer, nevertheless the majority of them did not know about oral
cancer’s signs and symptoms, risk factors and oral cancer examination 48.
Despite that some authors recommend the clinical evaluation, the criteria
between evaluators may vary making successful early detection more
challenging. In this project it was evident that of 39 mice that received the
carcinogen agent, one evaluator considered that only 21 tongues showed
possible clinical changes while the other evaluator considered that in 15 tongues
possible changes were noted, and that 24 tongues had some premalignant
changes. Nevertheless, 5 of the 10 tongues of the control group, that didn't
receive any carcinogen agent in the drinking water, were evaluated as having a
possible lesion or a lesion. Despite that the clinical evaluation is the exam most
recommended by many clinicians it may have the potential to generate false
positives and false negatives

49

. Although it is important to continue to clarify the

public health message and promote primary prevention, an important action that
could help in the prevention of the oral cancer is determining the feasibility of a
national screening program. Despite this strategy designed to enhance early
detection of new cases, some authors consider that diagnosing early malignancy
by only its visual appearance is not possible 49.
A clinical evaluation must not be limited to the oral cavity. A physical examination
is recommended, which must include evaluation of the head and neck, and
exhaustive examination of the oral cavity, inspection and palpation of all mucosal
surfaces, skin, scalp, tongue, hard and soft palate, dentition and cervical nodes18.
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Some authors suggest that clinical evaluation has limited value as a method for
detecting potentially malignant lesions while others have reported that this
examination has a high degree of sensitivity and specificity for detection of oral
cancer 50.
In this study there was a marked difference in the results obtained in the clinical
evaluation of the specimens and the histological results. One of the evaluators
was slightly precise in the identification especially for the specimens in the
treated group, while the other examiner was moderately precise in the
identification of the control and treated specimens. However, the results
demonstrated that the clinical examination may vary between examiners. This
kind of difference in the criteria may result in false positives or false negatives.
Rethman stated that one of the limitations found in the clinical evaluation is that
premalignant lesions often are asymptomatic and may mimic other conditions,
whereas others may not be readily evident in routine examination. Also, because
malignant and benign lesions may be clinically indistinguishable, the clinician
cannot predict the biological relevance of lesions on the basis of their physical
features alone

12

. Another aspect to be considered is that oral cancer at an early

stage is often dismissed as a traumatic or infective lesion
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. One of the largest

challenges of the evaluation of oral diseases is the dilemma of attempting to
predict which potentially malignant lesions will progress to neoplasia, notably oral
squamous cell carcinoma (OSCC). It is difficult to find distinctive clinical features
that differentiate benign, precancerous and early cancerous mucosal changes
51

.
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Many new techniques have been developed to aid the clinician in the screening
of areas with possible premalignant lesions. Almost all of these techniques are
non-invasive and this makes the patient feel more comfortable and less stressed
with the screening. Some of these devices included in oral screening are:
VELscope, Identafi, Narrow Band Imaging and OCT.
The VELscope (LED Medical Diagnostics Inc, Barnaby, Canada) is used to
excite endogenous fluorophores such as certain amino acids, metabolic products
and structural proteins. Nevertheless, some authors argued that not all dysplastic
lesions displayed loss of autofluorescence and its use could result in missed
lesions and a false positive 36.
Identafi (DentalEZ, PA, USA) is a multispectral screening device that has three
different lights designed to be used in a sequential manner to facilitate intraoral
examination. With Identafi normal mucosa exhibits natural fluorescence, whereas
abnormal tissues appear dark due to diminished autofluorescence. The ability to
differentiate between low and high risk lesions is difficult with this device 36.
Narrow Band Imaging (NBI; Olympus Medical Systems Corporation, Tokyo,
Japan) is an endoscopic visualization technology which enhances the mucosal
surface texture and underlying vasculature. NBI is based on the concept that the
wavelength of light determines the depth of penetration, and that changes in the
color of the superficial mucosa will be noted according to the extension of the
lesions. With a magnification of approximately 1.5 times digital zoom, NBI has
the potential to detect malignancies that might be missed with white light 36, 52.
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Despite the diversity of screening devices, none of these replaces conventional
visual and tactile examination of the oral soft tissues and are not diagnostic tests.
None of these devices can effectively differentiate which lesion is considered a
low risk or high risk 36, 46. It is important to recognize that the use of any visual aid
is only an adjunct to the rigorous clinical evaluation of the head and neck and will
never replace this important exam 51.
Another diagnostic aid that has been used is the transepithelial cytology (Oral
Cdx Brush Test, Suffern, NY). It consists of a disposable, circular plastic brush
that the dentist or clinician rubs against the suspicious area until pinpoint
bleeding is observed, confirming that the basement membrane was penetrated
and a transepithelial sample was acquired. While the OralCDx BrushTest has
demonstrated validity as an adjunct to lesion assessment in specific clinical
situations, practitioners must remember that the diagnostic gold standard for oral
cancers and potentially malignant lesions continues to be histopathological
examination of surgical biopsy specimens 12, 46.
Optical Coherence Tomography is a recently developed technique that has been
used in areas of ophthalmology, dermatology, gynecology and recently in
pulmonary, intravascular coronary and esophageal imaging. This high resolution
imaging modality generates cross-sectional images with endogenous contrast
based on variation in index of refraction. It has similar principles as ultrasound
but with higher resolution 53.
Comparison between OCT images and histopathology has been demonstrated in
studies of both rats and humans, showing that OCT images could provide
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microstructural information of malignant lesions

54

. One of the advantages

obtained with the use of the OCT is that this imaging technique reveals many
detailed morphologic features of malignant and abnormal tissues, that could be
potentially significant local regions with high metabolic activities and early
malignant changes

24

. Some of the architectural changes that OCT is capable of

showing are: keratinized cell layer, epithelial layer, basement membrane, lamina
propria and rete pegs of oral mucosa with the limitation that OCT does not
provide any cellular information to grade the potentially malignant lesions

36

resolution of the OCT is similar to low power microscopy, approximately 4X

. The
53

.

Optical Coherence Tomography (OCT) has the potential to provide immediate
and accurate diagnostic information, potentially reducing both the costs
associated with unnecessary biopsies and treatment delays

36

. OCT can aid in

guiding the clinician in the selection of the site to be biopsied, to ensure the
precision of the affected area and to increase diagnostic yield of the biopsied
tissue. It is recommended that the clinicians that will be using this imaging
technique must be familiar with the normal conditions of the oral cavity in all
aspects including clinical, histopathological and OCT imaging. The pathologist
plays an important role in the development and implementation of OCT in clinical
practice, using this technique as a complement to standard tissue pathology

53

.

However, in the present study the results obtained in the OCT evaluation were
considerably different between the examiners. One of the evaluators was highly
consistent with the classification of the specimens even though the final
diagnosis was not consistent with the histological results. On the other hand, the
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second examiner was moderately accurate in the classification of the specimens,
however was self consistent with the evaluation.
In contrast to the benefits of OCT referred to by many authors, potential
disadvantages are the limited backscattering contrast between normal and
dysplastic tissues, limited field of view and limitations in imaging depth

36

.

Another limitation of OCT is that it requires close proximity to the tissue being
imaged to get cross-sectional, depth resolved images with micrometer-scale
resolution without destruction or excision of the tissue

55

. Although this technique

is known by many authors as an optical biopsy, atypical cells are not
distinguished in the OCT

56

. However, the structural changes occurring in the

different layers of the epithelium can be visualized in OCT images. Epithelial
dysplasia is the most important predictor of malignant transformation and it can
only be diagnosed with histological specimens 57.
Regardless of all the advantages obtained with the use of all these new
techniques, none of these devices can be considered as a replacement for the
histological evaluation. While these devices may aid in the evaluation of the oral
cavity, it is important that these devices not be used in the hands of
inexperienced clinicians to avoid possible false positives or false negatives 57.
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CONCLUSIONS
Oral cancer is one of the most common types of cancer for which survival rates
haven't improved in the last years. Dentists and clinicians must consider
alternatives to be used to diagnose this disease in an early stage.
The oral cancer screening examination must be part of the daily practice. It is
recommended that every practitioner allow additional time to evaluate all the
tissues of the oral cavity, head and neck. However, this valuable exam may yield
variable results as in this study, in which clinical results differed widely between
both examiners. It is important that the clinician must be familiar with the normal
aspect of the oral tissues.
Many devices are offered to help the clinician in the screening of oral
malignancies. Despite the favorable results that manufacturers report, it is
important to emphasize that none of the visual aid devices will substitute for the
oral screening; these will be used as an adjunct to the clinical evaluation.
OCT has been demonstrated to be an excellent evaluation aid that may be used
to obtain information of the microstructural changes occurring in the oral
epithelium; it is helpful to identify suspicious areas where a histological
evaluation is recommended. The clinician must be familiar with the technique to
avoid any false positives or false negatives. It is recommended to receive training
in the use of the OCT, but most important is the necessity of knowing the normal
aspect of the tissue visualized via OCT.
Despite the fact that the images obtained with this high resolution imaging
technique resemble the architecture of the different layers of the epithelium, it
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has an important limitation: there is no information of the cellular changes
occurring in the evaluated tissue, and for this reason it may not replace the
histological evaluation or biopsy.
However, OCT is a valuable aid in the identification of microstructural changes
occurring in the epithelial layers of the oral cavity, with an image quality similar to
a low power microscope. This helps the clinician during the oral cancer
screening, to obtain immediately multiplanar imaging sections of the evaluated
area and 3D reconstruction of the area. Additionally, it may guide the clinician
with the correct identification of an affected area to be biopsied.
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FUTURE DIRECTIONS
For future studies it is recommended that additional examiners participate in the
evaluation of the images obtained in the present study, including specialists in
the different areas of dentistry that participate in the screening of patients.
Another aspect to consider in future evaluations is the use of a handheld OCT
device to be used in vivo in the oral cavity.
A similar study is recommended to evaluate architectural changes of the
epithelial layers of the oral cavity from early stage to an advanced stage of oral
squamous cell carcinoma.
Additionally, it is recommended that other hard components of the tooth, such as
enamel and dentin, be examined to evaluate the accuracy of the OCT in the
diagnosis of incipient caries.
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